Chonluten (20 mg Vial) Dosage Protocol

Quickstart Highlights

Chonluten dosage protocols focus on this short bioregulatory tripeptide (Glu-Asp-Gly) studied for respiratory health and bronchopulmonary tissue support^[1]^[2]. Research indicates Chonluten may help reduce chronic inflammation, support bronchial epithelium repair, and normalize antioxidant gene expression in lung tissue^[3]^[4]. By modulating pro-inflammatory cytokines like TNF-α and IL-6, Chonluten shows potential to improve airway function and exercise tolerance in respiratory conditions^[5]. This educational protocol presents a once-daily subcutaneous approach with gradual titration for research applications.

Reconstitute: Add 3.0 mL bacteriostatic water → 6.67 mg/mL concentration.

Typical daily range: 250–2000 mcg once daily (gradual titration over 8–12 weeks).

Easy measuring: At 6.67 mg/mL, 1 unit = 0.01 mL ≈ 66.7 mcg on a U-100 insulin syringe.

Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard / Gradual Approach (3 mL = ~6.67 mg/mL)

Week	Daily Dose (mcg)	Units (per injection) (mL)
Weeks 1–2	250 mcg	4 units (0.04 mL)
Weeks 3–4	500 mcg	8 units (0.08 mL)
Weeks 5–6	750 mcg	11 units (0.11 mL)
Weeks 7–8	1000 mcg (1 mg)	15 units (0.15 mL)
Weeks 9–10	1500 mcg (1.5 mg)	23 units (0.23 mL)
Weeks 11–12	2000 mcg (2 mg)	30 units (0.30 mL)

Frequency: Inject once daily subcutaneously at a consistent time. For ≤10-unit (≤0.10 mL) administrations during early weeks, consider 30- or 50-unit insulin syringes for improved readability.

Advanced / Extended Approach (Weeks 13–16)

Week	Daily Dose (mcg)	Units (per injection) (mL)
Weeks 13–14	3000 mcg (3 mg)	45 units (0.45 mL)
Weeks 15–16	4000 mcg (4 mg)	60 units (0.60 mL)

Advanced dosing (3–4 mg/day) should only be employed if lower doses are well-tolerated. Clear dose-response data in humans are limited; such doses represent the high end of research protocols.

Reconstitution Steps

Draw 3.0 mL bacteriostatic water with a sterile syringe.

Inject slowly down the vial wall; avoid foaming.

Gently swirl/roll until dissolved (do not shake).

Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Plan based on an 8–16 week daily protocol with gradual titration.

Peptide Vials (Chonluten, 20 mg each):

8 weeks ≈ 2 vials (~35 mg total usage)
12 weeks ≈ 5 vials (~84 mg total usage)
16 weeks ≈ 10 vials (~182 mg total usage)

Insulin Syringes (U-100):

Per week: 7 syringes (1/day)
8 weeks: 56 syringes
12 weeks: 84 syringes
16 weeks: 112 syringes

Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.

8 weeks (2 vials): 6 mL → 1 × 10 mL bottle
12 weeks (5 vials): 15 mL → 2 × 10 mL bottles
16 weeks (10 vials): 30 mL → 3 × 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each day.

Per week: 14 swabs (2/day)
8 weeks: 112 swabs → recommend 2 × 100-count boxes
12 weeks: 168 swabs → recommend 2 × 100-count boxes
16 weeks: 224 swabs → recommend 3 × 100-count boxes

View Supplier

Protocol Overview

Concise summary of the once-daily regimen.

Goal: Support bronchopulmonary tissue repair and reduce chronic inflammation over time^[1]^[3].

Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks for advanced protocols).

Dose Range: 250–2000 mcg daily with gradual titration; up to 4000 mcg in extended protocols.

Reconstitution: 3.0 mL per 20 mg vial (~6.67 mg/mL) for accurate unit measurements.

Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Research Disclaimer

Chonluten (20mg Vial) Dosage Protocol